AFP
IDXX icon

Ausdal Financial Partners’s Idexx Laboratories IDXX Stock Holding History

Ausdal Financial Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$342K Sell
650
-479
-42% -$269K 0.01% 773
2026
Q1 		$634K Buy
1,129
+99
+10% +$63.5K 0.03% 508
2025
Q4 		$697K Buy
1,030
+338
+49% +$230K 0.03% 448
2025
Q3 		$442K Buy
692
+123
+22% +$74.7K 0.02% 593
2025
Q2 		$305K Buy
569
+63
+12% +$30.1K 0.02% 543
2025
Q1 		$212K Sell
506
-44
-8% -$19.1K 0.02% 590
2024
Q4 		$227K Buy
550
+5
+0.9% +$2.19K 0.02% 520
2024
Q3 		$275K Sell
545
-58
-10% -$28.2K 0.03% 425
2024
Q2 		$294K Sell
603
-76
-11% -$38.2K 0.03% 398
2024
Q1 		$367K Sell
679
-12
-2% -$6.56K 0.04% 330
2023
Q4 		$384K Buy
691
+4
+0.6% +$1.88K 0.05% 299
2023
Q3 		$300K Sell
687
-9
-1% -$4.49K 0.04% 337
2023
Q2 		$350K Sell
696
-24
-3% -$11.5K 0.05% 297
2023
Q1 		$360K Buy
720
+2
+0.3% +$957 0.05% 302
2022
Q4 		$293K Buy
718
+50
+7% +$19.4K 0.04% 344
2022
Q3 		$218K Buy
668
+7
+1% +$2.57K 0.03% 393
2022
Q2 		$232K Hold
661
– – 0.04% 392
2022
Q1 		$362K Hold
661
– – 0.05% 335
2021
Q4 		$435K Hold
661
– – 0.06% 301
2021
Q3 		$411K Hold
661
– – 0.06% 307
2021
Q2 		$417K Hold
661
– – 0.06% 291
2021
Q1 		$323K Buy
661
+6
+0.9% +$3.01K 0.05% 324
2020
Q4 		$327K Sell
655
-10
-2% -$4.47K 0.06% 296
2020
Q3 		$261K Buy
+665
New +$246K 0.06% 284

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Ausdal Financial Partners's IDXX Position: Q2 2026 in Review

Ausdal Financial Partners reduced its Idexx Laboratories (IDXX) stake by 42% in Q2 2026, selling an estimated $269K and leaving 650 shares worth $342K. The position accounts for 0.01% of the portfolio, ranked #773.

Ausdal Financial Partners first reported a position in IDXX in Q3 2020 and has held it in 24 quarters since. The position peaked at $697K in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Ausdal Financial Partners held 650 shares of Idexx Laboratories worth $342K as of Q2 2026.
  • Ausdal Financial Partners sold 479 Idexx Laboratories shares in Q2 2026, an estimated $269K.
  • Idexx Laboratories made up 0.01% of Ausdal Financial Partners's portfolio in Q2 2026, its #773 holding.
  • Ausdal Financial Partners first reported a position in Idexx Laboratories in Q3 2020 and has held it in 24 quarters since.
  • Ausdal Financial Partners's Idexx Laboratories position peaked at $697K in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Ausdal Financial Partners's 13F filing for Q2 2026, filed 14 Aug 2026.